·1 хв читання · 73 слова·👁 5.3K↗ 11
HSA grants interim authorisation for Novavax's Nuvaxovid Covid-19 vaccine
The vaccine will be made available for individuals aged 18 years and above and comprises 2 5-microgram doses, which are to be administered 3 weeks apart.
Under the interim authorisation, Novavax is required to monitor the longer-term efficacy of Nuvaxovid to determine the duration of protection against Covid-19, HSA said.
The first batch is slated to arrive in Singapore in the next few months.
